KZA 0.00% 8.0¢ kazia therapeutics limited

Alliance A071701: Genomically guided treatment trial in brain metastases., page-21

  1. 2,071 Posts.
    lightbulb Created with Sketch. 443
    Don't think update will happen. I'm one of the investors assuming that Brastianos will cite disordered PI3K as a common target in primary and secondary cancers.

    There's also the possibility it'll be mentioned with regards to breast cancer brain metastases. All you can do is listen-in.
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.